Advent and Warburg Pincus complete $4.25bn BPS acquisition
Global private equity investor Advent International, and global growth investor Warburg Pincus, have completed their previously announced $4.25bn all-cash acquisition of Baxter International Inc’s BioPharma Solutions business.